User:Red Group: Difference between revisions
(New page: {{New user}} ==Info== thumb|right|Red Group(an artistic interpretation) *T/R Section Red Group *20.109 ==Possible Research Topics== <!-- Feel free to add brief d...) |
(No difference)
|
Revision as of 21:17, 28 April 2008
I am a new member of OpenWetWare!
Info
- T/R Section Red Group
- 20.109
Possible Research Topics
- Fusion of drugs to albumin antibodies to extend in vivo drug half-life
- Rational design of chimeric restriction enzymes
Research Topic 1
- Holt LJ, Basran A, Jones K, Chorlton J, Jespers LS, Brewis ND, and Tomlinson IM. Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs. Protein Eng Des Sel. 2008 May;21(5):283-8. DOI:10.1093/protein/gzm067 |
leave a comment about a paper here
This paper describes how fusing drugs with short half-lives to antibodies specific to albumin, which has a long half-life, extends the drug's half-life without destroying its efficacy.
Another reference is:
The pharmacokinetics of an albumin-binding Fab can be modulated as a function of affinity for albumin (Nguyen et al.) This paper describes the original creation of albumin-binding antibody-fused species, and the half-life-extending effects of this fusion.
Candidate topics for 20.109:
- Extend work to other drugs
- Test effect on IL-1ra on humans
- Explore other proteins to replace albumin, possibly increasing the effect
Research Topic 2
- Zhang P, Bao Y, Higgins L, and Xu SY. Rational design of a chimeric endonuclease targeted to NotI recognition site. Protein Eng Des Sel. 2007 Oct;20(10):497-504. DOI:10.1093/protein/gzm049 |
leave a comment about a paper here
Please copy the source code from this page to your user page, fill in the answers and print out a copy for next time.
You do not need to keep the information on your user page once you've printed it out.